Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

‘It's definitely not Alzheimer's’: Perceived benefits and drawbacks of a mild cognitive impairment diagnosis

‘It's definitely not Alzheimer's’: Perceived benefits and drawbacks of a mild cognitive... BackgroundMild cognitive impairment (MCI) describes a level of cognitive impairment between that seen in ‘normal’ ageing and dementia. MCI was identified in the clinical literature as early as the mid‐1990s (e.g., Petersen, ), but interest in the syndrome increased following the publication of formal MCI criteria by Ronald Petersen's Mayo Clinic team (Petersen et al., ). These criteria consisted of (1) memory complaint, preferably corroborated by an informant; (2) objective memory impairment; (3) preserved general cognition; (4) intact activities of daily living; and (5) no dementia. Petersen et al. () followed a cohort of people who met these criteria and found a greater rate of cognitive decline than that seen in healthy older adults over time, but not as great as that observed in a comparison group of people with mild Alzheimer's disease (AD). In addition, the MCI group showed impairment only in memory, while those with mild AD had accompanying deficits in other cognitive domains. Consequently, it was argued that MCI was a distinct clinical syndrome worthy of further study.Since then, MCI has been a subject of debate and investigation with respect to prevalence (Ward, Arrighi, Michaels, & Cedarbaum, ), existence and prognostic value of different subtypes (Mitchell & Shiri‐Feshki, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png British Journal of Health Psychology Wiley

‘It's definitely not Alzheimer's’: Perceived benefits and drawbacks of a mild cognitive impairment diagnosis

Download PDF
19 pages

Loading next page...
 
/lp/wiley/it-s-definitely-not-alzheimer-s-perceived-benefits-and-drawbacks-of-a-DIN2gjOO3S

References (47)

Publisher
Wiley
Copyright
© 2017 The British Psychological Society
ISSN
1359-107X
eISSN
2044-8287
DOI
10.1111/bjhp.12255
pmid
28628736
Publisher site
See Article on Publisher Site

Abstract

BackgroundMild cognitive impairment (MCI) describes a level of cognitive impairment between that seen in ‘normal’ ageing and dementia. MCI was identified in the clinical literature as early as the mid‐1990s (e.g., Petersen, ), but interest in the syndrome increased following the publication of formal MCI criteria by Ronald Petersen's Mayo Clinic team (Petersen et al., ). These criteria consisted of (1) memory complaint, preferably corroborated by an informant; (2) objective memory impairment; (3) preserved general cognition; (4) intact activities of daily living; and (5) no dementia. Petersen et al. () followed a cohort of people who met these criteria and found a greater rate of cognitive decline than that seen in healthy older adults over time, but not as great as that observed in a comparison group of people with mild Alzheimer's disease (AD). In addition, the MCI group showed impairment only in memory, while those with mild AD had accompanying deficits in other cognitive domains. Consequently, it was argued that MCI was a distinct clinical syndrome worthy of further study.Since then, MCI has been a subject of debate and investigation with respect to prevalence (Ward, Arrighi, Michaels, & Cedarbaum, ), existence and prognostic value of different subtypes (Mitchell & Shiri‐Feshki,

Journal

British Journal of Health Psychology – Wiley

Published: Nov 1, 2017

Keywords: ; ; ; ; ; ; ; ; ; ;

There are no references for this article.